Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03237624 · ClinicalTrials.gov registry record · NA

Functional Chewing Gum in Reduction of Gingival Inflammation

A NA study, sponsored by University of Maryland, Baltimore.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT03237624 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03237624, a NA study, has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

The aim of this prospective randomized 3-month double-blinded single center study is to determine whether a chewing gum device with food additive chitosan, will aid in reducing gingival inflammation by supplementing traditional tooth brushing and flossing measures. Patients with mild to moderate gingivitis will be identified and enrolled in this investigation. All enrolled subjects will receive baseline oral hygiene brushing instructions and a baseline clinical examination of the gingiva. The test group will utilize the test chewing gum three times a day for a minimum 20-30 minutes duration; the control group will receive a placebo gum and use it in a similar manner. We will examine whether daily use of a functional chewing gum enhances improvements to brushing and flossing.

Interventions

  • DEVICE Functional Chitosan Chewing Gum
  • DEVICE Control Chewing Gum
  • BEHAVIORAL Oral hygiene measures

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2018-01-31
Est. Completion 2020-01-31
Phase NA

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT03237624

The ClinicalTrials.gov registry entry for NCT03237624 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Functional Chitosan Chewing Gum is the first listed.

NCT03237624 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03237624 about?

NCT03237624 is a clinical study titled "Functional Chewing Gum in Reduction of Gingival Inflammation". The aim of this prospective randomized 3-month double-blinded single center study is to determine whether a chewing gum device with food additive chitosan, will aid in reducing gingival inflammation by supplementing traditional tooth brushing and flossing measures. Patients with mild to moderate gin...

What is the current status of trial NCT03237624?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2018-01-31. Estimated completion is 2020-01-31.

What interventions are being tested in trial NCT03237624?

The interventions under investigation include: Functional Chitosan Chewing Gum (DEVICE), Control Chewing Gum (DEVICE), Oral hygiene measures (BEHAVIORAL).

Who is sponsoring clinical trial NCT03237624?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.